The preferential localization pattern of PTK6 appears to differ between normal vs tumor cells, which could account for differential access to substrates and differential activities in these contexts; while PTK6 is expressed in the nucleus of normal luminal prostate epithelial cells, PTK6 is largely cytosolic in more aggressive prostate cancer cells [4, 12]. This evidence concerns the gene PTK6 and prostate carcinoma.